[CLINICAL TRIAL OF A NEW TRANQUILIZER, A BENZODIAZEPINE SERIES DERIVATIVE: RO 5-2807].
D001007:Anxiety; D001008:Anxiety Disorders; D001342:Autonomic Nervous System Diseases; D001569:Benzodiazepines; D003130:Combat Disorders; D003863:Depression; D003975:Diazepam; D006801:Humans; D006998:Hypochondriasis; D007046:Hysteria; D002537:Intracranial Arteriosclerosis; D001523:Mental Disorders; D009497:Neurotic Disorders; D009771:Obsessive-Compulsive Disorder; D012559:Schizophrenia; D013064:Speech Disorders; D020323:Tics; D014149:Tranquilizing Agents; D014857:Warfare
D014149:Tranquilizing Agents; D001569:Benzodiazepines; D003975:Diazepam
AUTONOMIC DYSFUNCTION; CEREBRAL ARTERIOSCLEROSIS; DEPRESSION; DIAZEPAM; HYPOCHONDRIASIS; HYSTERIA; MENTAL DISORDERS; NEUROSES, ANXIETY; NEUROSES, OBSESSIVE COMPULSIVE; NEUROSES, WAR; SCHIZOPHRENIA; SPEECH DISORDERS; TIC; TRANQUILIZING AGENTS
ESSAI CLINIQUE D'UN NOUVEAU TRANQUILLISANT, D'ERIV'E DE LA S'ERIE DES BENZODIAZ'EPINES: LE RO 5-2807.